Site map

• bioTheranotics (Home)
• About Us
  • About bioTheranostics
  • Company History
  • Company Guiding Principles
  • Management Team
  • Careers
• Products & Services
  • Patients & Caregivers
    • THEROS CancerTYPE ID Overview
      • Types of Cancer
      • Understanding Metastatic Cancer
      • FAQs
    • THEROS Breast Cancer Index Overview
      • Understanding Your Diagnostic Workup
      • Frequently Asked Questions
    • Patients Assistance Program
  • Healthcare Professionals
    • THEROS CancerTYPE ID Overview
      • Primary Cancer Origin
      • Classification Process
      • The Test Report
      • Insurance and Reimbursement
      • Frequently Asked Questions
    • THEROS Breast Cancer Index Overview
      • Risk Stratification
      • Tumor Grading
      • Recurrence Risk
      • H/I Details
      • MGI Details
      • The Test Report
      • Insurance and Reimbursement
      • Frequently Asked Questions
• Information Center
  • Press Room
    • bioTheranostics Carcinoma of Unknown Primary (CUP) Technology Highlighted in Case Study Published in New England Journal of Medicine
      
    • Arcturus Partnership Gives Agendia European Rights to TUO Gene Expression Profile for CupPrintT Diagnostic Test
      
    • bioTheranostics Announces CAP Accreditation of Its Laboratory Operations
      
    • bioTheranostics confirms that combination of two molecular biomarkers improves prediction of disease recurrence in early stage breast cancer patients
    • bioTheranostics presents at 2007 BIOCOM Investor Conference
      
    • Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
    • CONNECT ANNOUNCES FINALISTS FOR 20th ANNUAL MOST INNOVATIVE NEW PRODUCT AWARDS
      
    • Quest Diagnostics Launches Test to Help Oncologists Predict Risk of Breast Cancer Recurrence in Women with Estrogen Receptor (ER)-Positive, Lymph Node- Negative Cancers
      
    • Study Links HOXB13 & IL17BR with Estrogen Signaling in Breast Cancer
      
    • Three Clinical Studies of bioTheranosticsMolecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
      
  • Events
  • Publications & Presentations
  • Downloads
  • Glossary
• Ordering A Test
  • How to Order A Test
• Register For Updates
  • Patients & Caregivers
  • Healthcare Professionals
• Privacy Policy
• bioTheranostics Privacy Statement
• Terms and Conditions
• Contact Us